Extraskeletal osteosarcoma and its histological mimics

•EOS contains bone but other sarcomas may rarely produce bone and thus histologically mimic EOS.•Benign lesions producing immature bone and cartilage may histologically mimic EOS on core needle biopsy.•EOS with focal bone formation may require extensive sampling, IHC and sequencing for correct diagn...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human Pathology Reports 2022-06, Vol.28, p.300639, Article 300639
Hauptverfasser: Yenwongfai, Leonard N., Liu, Jinpeng, Wang, Chi, Bocklage, Therese J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•EOS contains bone but other sarcomas may rarely produce bone and thus histologically mimic EOS.•Benign lesions producing immature bone and cartilage may histologically mimic EOS on core needle biopsy.•EOS with focal bone formation may require extensive sampling, IHC and sequencing for correct diagnosis.•MDM2 and CDK4 amplifications may occur in EOS but do not correlate with improved prognosis.•Best chemotherapy for treating EOE is controversial with conclusions hampered by lack of prospective data. Extraskeletal osteosarcoma (EOS) is a sarcoma primary to soft tissue that produces tumor osteoid or bone (mineralized osteoid). It is rare, occurs generally in middle-aged to older adults in the extremities, and typically is histologically high grade. There are no diagnostically helpful findings of EOS prior to biopsy, as the clinical presentation is non-specific, and imaging studies may not demonstrate mineralization. Core needle biopsies may fail to sample neoplastic osteoid/bone, rendering specific diagnosis on these small tissue specimens challenging. Even if a core biopsy yields osteoid, the diagnosis is not straightforward, as the histologic differential diagnosis of EOS is broad. Other sarcomas primary to soft tissue may occasionally produce bone or osteoid, such as dedifferentiated liposarcoma and synovial sarcoma, among others, thereby mimicking EOS. Depending on the body site involved, such as superficial location in the head and neck, non-mesenchymal tumors also enter the differential such as sarcomatoid carcinoma. To further complicate diagnostic evaluation, certain benign mesenchymal tumors that form reactive, hypercellular osteoid/bone may be mistaken for extraskeletal osteosarcoma such as myositis ossificans. Thus, correct diagnosis of EOS requires excluding these other malignant and even benign entities that contain tumoral osteoid and/or hypercellular reactive bone. Ancillary testing, including immunohistochemistry and molecular genetic analysis, may be necessary to reach the correct diagnosis.
ISSN:2772-736X
2772-736X
DOI:10.1016/j.hpr.2022.300639